Sepsis assay arms clinicians with crucial intel in less than 3 hours
Microbio’s flagship assay, InfectID-BSI, arms clinicians with a potent new weapon when treating sepsis. It complements blood culture by allowing clinicians to identify the underlying infection and its precise bioburden in 19 out of 20 patients within 3 hours of laboratory time
Accurate diagnosis for >94% of sepsis patients
InfectID-BSI identifies the 26 pathogens (20 bacteria and 6 yeast) which collectively are responsible for >94% of all sepsis cases, including several which blood culture struggles to grow.
Minimally invasive blood draw
InfectID-BSI is validated with samples as small as 0.4 mL—ideal for neonates or patients weakened by trauma, disease or therapy.
Early targeting of antimicrobials
By delivering clinically actionable intel in less than 3 hours, InfectID-BSI enables clinicians to prescribe specific antimicrobials early.
Powerful rule-out test
InfectID-BSI has demonstrated a negative predictive value of 99.74% in a patient sample study.
Go Further
Get a better understanding Microbio with our long read articles.
Interested in InfectID-BSI?
Contact us to purchase or become a distributor